COVID-19 surge continues: Maharashtra, Kerala and Punjab account for 76.48% of country’s total active cases

[ad_1]

Read More/Less


Sixteen States/Union Territories have not reported any COVID-19 deaths in the last 24 hours.

Three States — Maharashtra, Kerala and Punjab account for 76.48% of India’s total active cases currently with the country on Friday reporting 39,726 new COVID-19 cases, 20,654 recoveries and 154 deaths in the last 24 hours, as per data released by the Health Ministry.

“Some states in the country are reporting a surge in the daily new COVID-19 cases. Maharashtra, Punjab, Karnataka, Gujarat and Chhattisgarh together account 80.63% of the daily new cases,’’ said the release.

It added that Maharashtra continued to report the highest daily new cases at 25,833 (65% of the daily cases). It is followed by Punjab with 2,369 while Kerala reported 1,899 new cases. India’s total active caseload stands at 2.71 lakh (2,71,282) on Friday.

The release added that the country’s cumulative recoveries stand at 1,10,83,679 on Friday with a national recovery rate of 96.56%.

Sixteen States/Union Territories have not reported any COVID-19 deaths in the last 24 hours. These include — Andhra Pradesh, Chandigarh, Odisha, Uttarakhand, Jharkhand, Lakshadweep, Sikkim, Meghalaya and Arunachal Pradesh.

IMA appeal

Meanwhile, the India Medical Association (IMA) in a release issued on Friday said that it was painful to note that despite adequate health care, infrastructure encasement, public awareness and stringent control measures for the mitigation of Coronavirus pandemic in India, there was a continuous spike in the cases streaking across the country forecasting the beginning of the second wave.

“We urge everyone to come forward with a more dedicated test, trace and carry on appropriate protocol for treating without falling prey to unscientific selfish-centered promotion of certain drugs and procedures,’’ noted the release.

Association national president J. A. Jayalal said: “In this context, we have raised questions on the usage of certain tablets (Coronil) as a medicine for the Corona infection. When questions were sent to Central Drug Standard Control Organisation through RTI it replied that no certificate or permission for the use of Coronil for treatment of COVID-19 is given by them.’’

He added that while the IMA acknowledged and respected the valuable contribution of pure Ayurveda drugs, “using it as an only curative drug for infected people will be a dangerous one. In the pandemic, we need to be extra cautious as any false hope will enhance the spread of the disease. Everyone should take the COVID-19 vaccination and adopt the principles of COVID-19 appropriate behaviours like physical distancing, hand hygiene, respiratory hygiene and appropriate masking to protect the people from spread of infection,’’ he said.

[ad_2]

READ FULL ARTICLE HERE

Using AI to fight COVID-19 may harm disadvantaged groups, experts say

[ad_1]

Read More/Less


The university’s researchers also highlighted discrimination in AI technology as they pick symptom profiles from medical records, reflecting and exacerbating biases against minorities

(Subscribe to our Today’s Cache newsletter for a quick snapshot of top 5 tech stories. Click here to subscribe for free.)

Companies worldwide have devised methods in the past year to harness the power of big data and machine learning (ML) in medicine. A model developed by Massachusetts Institute of Technology (MIT) uses AI to detect asymptomatic COVID-19 patients through coughs recorded on their smartphones. In South Korea, a company used cloud computing to scan chest X-rays to monitor infected patients.

Artificial intelligence (AI) and ML have been extensively deployed during the pandemic, and their use ranged from data extraction to vaccine distribution. But experts from the University of Cambridge raise questions on ethical use of AI as they see the technology to have a tendency to harm minorities and those from lower socio-economic status.

“Relaxing ethical requirements in a crisis could have unintended harmful consequences that last well beyond the life of the pandemic,” said Stephen Cave, Director of Cambridge’s Center for the Future of Intelligence (CFI).

Also Read | Competition between prediction algorithms is bad for customers, study finds

Making clinical choices like predicting deterioration rates of patients who may need ventilation can be flawed as the AI model uses biased data. These trained datasets and algorithms are inevitably skewed against groups that access health services infrequently, including minority ethnic communities and those belonging to lower social status, Cambridge team warned.

Another issue is in the way algorithms are used to allocate vaccines locally, nationally and globally. Last December, Stanford Medical Centre’s vaccination plan algorithm left out several young front-line workers.

“In many cases, AI plays a central role in determining who is best placed to survive the pandemic. In a health crisis of this magnitude, the stakes for fairness and equity are extremely high,” said Alexa Hagerty, research associate at University of Cambridge.

Also Read | How bias crept into AI-powered technologies

The university’s researchers also highlighted discrimination in AI technology as they pick symptom profiles from medical records, reflecting and exacerbating biases against minorities.

The use of contact-tracing apps has also been criticised by several experts around the world, stating that it excludes those who don’t have access to the internet and those who lack digital skills, among other user privacy issues.

In India, biometric identity programmes can be linked to vaccination distribution, raising concerns for data privacy and security. Other vaccine allocation algorithms, including some used by the COVAX alliance, are driven by privately owned AI. These private algorithms are like ‘black box’, Hagerty noted.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus Vaccine: Would it help if you had the choice to choose your vaccine? | The Times of India

[ad_1]

Read More/Less


In the future weeks, there may come a time when we get to select the vaccine of our choice or the way we get it.

The differences, between vaccines, exist but are very small right now.

For example, a big distinction between the vaccines used right now is the manner in which they are made. mRNA vaccines (Moderna and Pfizer’s) use a novel approach to make antibodies in the body, whereas traditional vaccines (such as Oxford-Astrazeneca, Covaxin) use an inactive strain of the virus to train the immune system.

The vaccines being administrated right now are also mostly two-dose regimes, which work best when injected weeks apart. The only real difference is, while mRNA vaccines have a lower waiting time between the doses, traditional vaccines can be injected upto 6 weeks after the initial dose.

In comparison to them, Johnson and Johnson’s unique one-dose vaccine, which has just been recently won nods for usage may be a better selling point and a better option to choose when it is made available.

As for the side-effects, almost all of the COVID-19 vaccines are known to cause similar-ranging reactions which can be mild or moderate.

[ad_2]

READ FULL ARTICLE HERE

One new Covid-19 case in Andamans | India News – Times of India

[ad_1]

Read More/Less


PORT BLAIR: One more person tested positive for Covid-19 in Andaman and Nicobar Islands, pushing the tally in the union territory to 5,036, a health department official said on Friday.
Two more persons recuperated from the disease in the last 24 hours, taking the total number of Covid-19 recoveries to 4,969, the official said.
The archipelago now has five active Covid-19 cases and all the five patients are in South Andaman district, he said.
The Covid-19 death toll remained at 62 as no new fatality due to the infection was reported in the last 24 hours.
The union territory administration has so far tested 2,99,048 samples for Covid-19 and the test positivity rate is 1.68 per cent, he said.
Altogether, 12,303 health care and frontline workers have been inoculated in the union territory till Thursday, and 1,865 people above 45 years of age have received the vaccine shots, the official said.
A total of 4,169 health care workers have also received the second dose of the vaccine.

[ad_2]

READ FULL ARTICLE HERE

Business Live:

[ad_1]

Read More/Less


The Nifty and the Sensex opened the day on a

Join us as we follow the top business news through the day.

9:30 AM

Delhi HC stays Future on Reliance deal

In a major victory for U.S.-based e-commence giant Amazon, the Delhi High Court on Thursday ruled that Future Retail Limited (FRL) and its promoters including Kishore Biyani “deliberately and wilfully” violated the order of an emergency arbitrator (EA) restraining FRL from going ahead with its assets sale deal with Reliance Retail.

Noting that the intention of FRL and its promoters “do not appear to be honest”, the high court directed attachment of the assets of Future Coupons Private Limited (FCPL), FRL, Mr. Biyani and 10 other promoters.

Justice J.R. Midha also directed Mr. Biyani and the other promoters to be present before the court on the next date of hearing on April 28. It additionally issued show-cause notices to all the promoters “to show cause why they be not detained in civil prison for a term not exceeding three months” for violation of the emergency arbitrator’s order.

 

[ad_2]

READ FULL ARTICLE HERE

Coronavirus live upates | Centre’s move to stop vaccine exports might affect U.K.: Adar Poonawalla

[ad_1]

Read More/Less


Maharashtra, Kerala and Punjab together account for 76.4% of active COVID-19 cases currently, with Maharashtra alone contributing nearly 60%, said data released by the Health Ministry on Wednesday.

You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.

Here are the latest updates:

Karnataka

Three new COVID-19 clusters emerge in Yelahanka zone in Bengaluru

Three new clusters have been detected in Yelahanka zone, taking the total number of active clusters to five. However, contact tracing is proving to be a nightmare as one family visited a temple despite being asked to remain in home isolation.

Among the new clusters, seven residents of an apartment in Vidyaranyapura ward have tested positive for COVID-19. The first positive case was detected on March 8 after a person returned from Kerala and developed symptoms. As a precautionary measure, BBMP health officials had advised other residents to stay indoors, even though they all initially tested negative.

However, one family went to ISKCON temple on March 9. The four family members developed symptoms on March 14 and tested positive the next day. On March 17, two more residents tested positive.

“We have intimated our counterparts in West zone. They will have to inform ISKCON authorities. It is very difficult to trace the secondary contacts, who may have visited the temple the same day as the family,” a health officer said.

Maharashtra

‘Rising cases may lead RBI to delay liquidity normalisation’

India’s central bank may have to delay the start of monetary policy normalisation by three months amid rising COVID-19 cases, but barring the return of stringent lockdowns there is no significant threat to the economy’s recovery, analysts say.

Having seen a peak of daily cases of almost 1,00,000 in late September, infections had been on a steady decline but have now started rising again over the last month.

“Even as the increase in the current caseload points to the risk of a second wave, more localised and less stringent restrictions will help contain the economic impact versus the initial wave,” said Radhika Rao, an economist with DBS Bank.

DBS has retained its assumptions for a stronger pick-up in March quarter growth versus the December 2020 quarter.

Karnataka

Karnataka govt. hospitals to ready 1,000 beds soon

With a second wave of COVID-19 outbreak imminent and three more clusters detected in Bengaluru on Thursday, the Karnataka government is gearing up to keep hospitals equipped.

As many as 1,000 COVID-19 beds will be readied in government hospitals and government medical colleges in the next 15 days, Health and Medical Education Minister K. Sudhakar said.

Addressing presspersons on Thursday after a meeting with senior health officials and heads of government hospitals and medical colleges, the Minister said he had asked all hospitals to keep beds ready on a mission mode. This apart, nearly 1,000 beds would also become functional from Monday in three COVID-19 care centres being set up in Bengaluru.

Gujarat

Amid rise in cases, Gujarat imposes additional curbs

The Gujarat government on Thursday imposed additional restrictions, including shutting down of schools and colleges, cancelling exams scheduled for college students and also shutting down malls/ shopping plazas and multiplexes on the weekends amidst rising COVID-19 cases in the second wave.

The State on Thursday recorded 1,276 cases and three deaths as the second wave of pandemic has struck, with alarming numbers of new infections in cities like Ahmedabad and Surat.

In Ahmedabad and Surat, the civic bodies have also increased the timing of night curfew from 9 p.m. to 6 a.m. while public transport bus services have been halted and all public parks, gardens and gyms have been shut in order to prevent people from gathering as the infection is surging.

New Delhi

Over 3.89 cr. vaccine doses administered so far: Centre

The cumulative number of COVID-19 vaccine doses administered in the country has crossed 3.89 crore on Thursday, the Union Health Ministry said on Thursday.

A total of 3,89,20,259 vaccine doses have been given, as per the provisional report till 7 p.m. on Thursday.

They include 76,19,786 to Health Care Workers (HCWs) who have taken the first dose and 46,92,962 HCWs who have taken the second dose, 78,11,126 Frontline Workers (FLWs) (first dose), 21,50,198 FLWs (second dose), 1,39,18,245 beneficiaries more than 60 years old and 27,27,942 beneficiaries aged 45 and above with specific co-morbidities.

A total of 17,83,303 vaccine doses have been given till 7 p.m. on Thursday, the 62nd day of nation-wide vaccination.

Tamil Nadu

Govt. hospitals get ready for surge in cases

With the number of fresh COVID-19 infections steadily rising in the city, the government hospitals are in a state of preparedness.

The infrastructure created was in place and the hospitals are gearing up to add more facilities and manpower in case of a surge.

The major government medical college hospitals set up exclusive COVID-19 facilities last year. As the number of fresh cases started to decline, the hospitals resumed their regular activities such as elective surgeries and outpatient services since October 2020.

In the last 10 days, the number of cases had been rising in Chennai. However, hospital authorities said the treatment facilities were intact.

The Netherlands

EU drug regulator backs AstraZeneca vaccine after safety investigation

The EU’s drug watchdog said on March 18 it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.

The news came as the European Medicines Agency (EMA) director Emer Cooke said the agency could not definitively rule out a link to blood clot incidents and the vaccine in its investigation into 30 cases of a rare blood clotting condition. It will however update its guidance to include an explanation about the potential risks for doctors and the public, she said.

The agency has been under growing pressure to clear up safety concerns after a small number of reports in recent weeks of bleeding, blood clots and low platelet counts in people who have received the shot.

Telangana

File status report on COVID-19 measures by April 6, HC tells Telangana

Telangana High Court on Thursday sought to know what steps had the State government taken to keep a tab on incidence of COVID-19 in the recently opened schools and colleges.

Observing that these places witness huge gatherings in classes and students would be appearing for exams in coming days, a bench of Chief Justice Hima Kohli and Justice B. Vijaysen Reddy said that it was imperative that the State focused on this aspect. “We keep hearing that second wave of coronavirus had hit many countries and we don’t want our State to go that way,” the bench noted.

The Bench wanted to know what measures the State government had initiated to screen passengers entering Telangana from neighbouring States of Maharashtra and Karnataka which witnessed a spike in COVID-19 cases. Those entering the State through bus stations, railway stations and airport were having the potential to spread the virus.

Karnataka

Centre says no to vaccination points in old age homes, care facilities

The Centre has ruled out the possibility of COVID-19 vaccination centres (CVCs) in old age homes and long-term care facilities, as CVCs have to meet certain requirements to provide safe vaccination. This has irked authorities of old age homes and other long-term care facilities.

The Centre’s “No” follows a request from Karnataka seeking permission to set up CVCs beyond health facilities (such as old age homes, long-term care facilities, apartment complexes and identified polling booths) to ramp up vaccination coverage among the elderly.

In a letter dated March 17 addressed to Jawaid Akhtar, Additional Chief Secretary (Health and Family Welfare), Vandana Gurnani, Union Additional Secretary and Mission Director, National Health Mission (NHM), has said that CVCs should have adequate space for vaccination, adequate cold chain arrangements for vaccine storage, arrangements for management of Adverse Events Following Immunisation (AEFI).

“These facilities would then also need to be registered on CoWIN to enable session planning, reporting of AEFI and allocation of vaccines. Based on the analysis done from Co-WIN, it is observed that out of 460 private health facilities empanelled under Ayushman Bharat – Arogya Karnataka (AB-ArK) in the State, only 55 are registered on Co-WIN,” the letter stated.

France

France announces soft new virus restrictions in Paris region

The French government backed off from ordering a tough lockdown for Paris and several other regions despite an increasingly alarming situation at hospitals with a rise in the numbers of COVID-19 patients.

Instead, the Prime Minister on March 18 announced a patchwork of new restrictions while reducing the national curfew by one hour.

Getting large doses of fresh air is being encouraged, meaning that people living in the Paris region and in the north of the country can walk as long as they like in a day, but within a 10-kilometre (6-mile) radius of their homes and with a paper authorising the stroll.

Stores, however, will feel the pinch with all non-essential outlets — but not bookshops — closing down. And travel between regions is forbidden without a compelling reason.

Maharashtra

Centre’s move to stop vaccine exports might affect United Kingdom

With India, and particularly Maharashtra, witnessing a renewed surge in COVID-19 cases, the United Kingdom’s vaccination programme could hit a roadblock as the Indian government is temporarily staying exports to address the increased domestic vaccination demands.

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India (SII) which is manufacturing the Oxford-AstraZeneca vaccine, told the UK’s Telegraph newspaper that the situation was solely dependent on the Indian government and had nothing to do with the SII.

“It is solely dependent on India and it has nothing to do with the SII. It is to do with the Indian government allowing more doses to the U.K.,” Mr. Poonawalla told The Telegraph.

According to the paper, Mr. Poonawalla confirmed that five million doses of the Oxford vaccine had already been delivered to the U.K. early this month.

[ad_2]

READ FULL ARTICLE HERE

Covid Pandemic Pushes 3.2 Cr Indians Below the Middle Class, Those Earning Less Than Rs 150 up by 7.5 Cr

[ad_1]

Read More/Less


Undoing years of economic gain, financial woes brought by a single year of the coronavirus pandemic pushed about 3.2 crore Indians out of the middle class, according to the US-based Pew Research Centre.

A year into the pandemic, the numbers of those in the middle class has shrunk to 6.6 crore, down a third from a pre-pandemic estimate of 9.9 crore, the report added.

“India is estimated to have seen a greater decrease in the middle class and a much sharper rise in poverty than China in the COVID-19 downturn,” the Pew Research Centre said, citing the World Bank’s forecasts of economic growth.

Nearly 5.7 crore people had joined the middle income group between 2011 and 2019, it added.

In January last year, the World Bank forecast almost the same level of economic growth for India and China, at 5.8 per cent and 5.9 per cent respectively, in 2020.

But nearly a year into the pandemic, the World Bank revised its forecast this January, to a contraction of 9.6 per cent for India and growth of 2 per cent for China.

India faces a second wave of infections in some industrial states, after a decline in cases until early this year, and its tally of 11.47 million is the highest after the United States and Brazil.

Prime Minister Narendra Modi’s government has taken steps to support the economy, while projecting a contraction of 8 per cent in the current financial year, which ends this month, before economic growth picks up to about 10 per cent in the next financial year.

The Pew Centre estimated the number of poor people, with incomes of USD 2 or less each day, has gone up by 7.5 crore as the recession brought by the virus has clawed back years of progress.

A rise of nearly 10 per cent in domestic fuel prices this year, job losses and salary cuts have further hurt millions of households, forcing many people to seek jobs overseas.

In China, however, the fall in living standards was modest as numbers in the middle-income category probably decreased by 1 crore, while poverty levels remained unchanged, the report added.

[ad_2]

READ FULL ARTICLE HERE

Chip shortage forces Ford to build trucks without computers

[ad_1]

Read More/Less


The move is the latest ripple from the global semiconductor shortage, which earlier this week forced Honda and Toyota to announce production cuts at some North American factories.

A global semiconductor shortage and a February winter storm have combined to force Ford to build F-150 pickup trucks without some computers.

The company says the pickups will be held at factories for “a number of weeks”, then shipped to dealers once computers are available and quality checks are done.

The move is the latest ripple from the global semiconductor shortage, which earlier this week forced Honda and Toyota to announce production cuts at some North American factories. General Motors also has been forced to build pickups without some computers and install them later.

Ford’s move is likely to tighten inventory of F-Series pickups, the top-selling vehicles in America. Inventories already are tight due to high demand and production losses due to last year’s coronavirus-related factory shutdowns.

Ford also said it will build the Edge SUV without computers and ship them later, and it will cancel some shifts on March 18 and 19 at an assembly plant in Louisville, Kentucky, where the Ford Escape SUV is made.

Automakers have said they don’t expect the chip shortage to get any better before the third quarter of the year. Ford has said the shortage could cut its pretax earnings by $1 billion to $2.5 billion, even if it makes up for some of the lost production in the second half of the year.

On March 18, Nissan too announced it would temporarily cancel production at factories in Smyrna, Tennessee; Canton, Mississippi; and in Aguascalientes, Mexico, due to the chip shortage. Some U.S. production lines will be down from March 19 through 22, while others will be idled just for the weekend. Aguascalientes Plant 1 will stop production through March 23.

Affected models include the Murano, Rogue, Maxima, Leaf, Altima, NV Vans, Kicks, Versa and March.

In addition, Volkswagen and Fiat Chrysler (now Stellantis) also say they have been affected by the shortage and forced to delay production of some models in order to keep other factories running.

Industry officials say semiconductor companies diverted production to consumer electronics during the worst of the COVID-19 slowdown in auto sales last spring. Global automakers were forced to close plants to prevent the spread of the virus. When automakers recovered, there weren’t enough chips as demand for personal electronics boomed.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Morning Digest: Roads to be freed of toll booths in a year, says Nitin Gadkari; EU drug regulator backs AstraZeneca vaccine against COVID-19 after safety investigation, and more

[ad_1]

Read More/Less


India will implement a GPS-based toll collection system and do away with all toll booths within a year, Union Minister for Road Transport and Highways Nitin Gadkari informed the Lok Sabha on Thursday. He also shared details of the vehicle scrapping policy, first announced in the Union Budget for 2021-22, according to which the automobile industry in India will see a jump in turnover to ₹10 lakh crore from ₹4.5 lakh crore.

Chief Justice of India Sharad A. Bobde agreed with advocate Prashant Bhushan on Thursday to urgently hear a plea by NGO Association for Democratic Reforms to stay the sale of a new set of electoral bonds on April 1, before Assembly elections in crucial States such as West Bengal and Tamil Nadu.

Top U.S. and Chinese officials offered sharply different views of the world on March 18 as the two sides met face-to-face for the first time since President Joe Biden took office. In unusually pointed remarks for a staid diplomatic meeting, Secretary of State Antony Blinken and Chinese Communist Party foreign affairs chief Yang Jiechi took aim at each other’s policies at the start of two days of talks in Alaska.

The EU’s drug watchdog said on March 18 it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.

The Rajya Sabha on Wednesday passed the Insurance Amendment Bill 2021 that increases the maximum foreign investment allowed in an insurance company from 49% to 74%, amid criticism from the Opposition parties on the clause enabling “control and ownership” by foreign investors.

The Supreme Court on Wednesday forbade judges from making gender stereotypical comments like “’good women are sexually chaste”, women who drink and smoke ‘ask’ for sexual advances or presume that a sexually active woman consented to rape while hearing cases of sexual offence.

Union Communications and Information Technology Minister Ravi Shankar Prasad said on Thursday that climate activist Disha Ravi’s arrest was based on law and order and it is under judicial process. He added that the House should consider “should some people abuse social media internationally to defame India to promote secessionism.”

Former Chief Economic Advisor (CEA) Arvind Subramanian resigned from Ashoka University on Thursday, days after noted columnist and political commentator Pratap Bhanu Mehta’s exit. In his resignation letter, Dr. Subramanian, said he had been “devastated” by “the circumstances involving the ‘resignation’ of Professor Pratap Bhanu Mehta” two days earlier.

In a major embarrassment to the Bharatiya Janata Party (BJP), two candidates announced by the party on Thursday for the Assembly polls from Kolkata have refused to contest on the party’s ticket.

The Supreme Court on Thursday stayed suo motu proceedings before the Delhi High Court on the administration of COVID-19 vaccine and transferred the case to itself. A Bench led by Chief Justice of India Sharad A. Bobde said a similar case concerning the vaccination drive was already pending in the Supreme Court, and the case from the Delhi High Court could be heard along with it.

The Supreme Court on Thursday agreed to urgently hear a plea to release and protect over 150 Rohingya refugees reportedly “detained” in Jammu. Chief Justice of India S.A. Bobde agreed to hear the application filed by a member of the Rohingya community, Mohammad Salimullah, represented by advocates Prashant Bhushan and Cheryl d’Souza, on April 25 (Thursday). Mr. Bhushan made an oral mention before the CJI for an early hearing.

The Lok Sabha on Thursday passed the supplementary demand for grants (second batch for 2020-21) but not before significant concerns raised by Opposition leaders on the government’s disinvestment and asset monetisation plans, and rising fuel prices.

If Ishan Kishan was unfortunate to be ruled out of the fourth T20I due to a groin strain, lady luck smiled on his replacement Suryakumar Yadav. The Mumbai cricketer, dropped for the previous outing after not having faced a ball on his debut in the second T20I, grabbed his chance and made it count.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

‘Rising cases may lead RBI to delay liquidity normalisation’

[ad_1]

Read More/Less


India’s central bank may have to delay the start of monetary policy normalisation by three months amid rising COVID-19 cases, but barring the return of stringent lockdowns there is no significant threat to the economy’s recovery, analysts say.

Having seen a peak of daily cases of almost 1,00,000 in late September, infections had been on a steady decline but have now started rising again over the last month.

“Even as the increase in the current caseload points to the risk of a second wave, more localised and less stringent restrictions will help contain the economic impact versus the initial wave,” said Radhika Rao, an economist with DBS Bank.

DBS has retained its assumptions for a stronger pick-up in March quarter growth versus the December 2020 quarter.

India reported 35,871 new coronavirus cases on Thursday, the highest in more than three months, with Maharashtra alone accounting for 65% of that.

Though analysts are unlikely to rush to review their growth forecasts, several believe policy normalisation, may now take a backseat.

“Monetary policy normalisation might be pushed back by a quarter as authorities monitor developments closely,” Ms. Rao said.

The RBI in early January said it wanted to start restoring normal liquidity operations in a phased manner.

“Growth concerns due to rising pandemic cases… could push back market expectations on the timing of policy normalisation,” Nomura economists Sonal Varma and Aurodeep Nandi wrote in a note.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

1 2 3 4 8